Future directions in nanotechnology-based drug development include the creation of smarter, stimuli-responsive nanocarriers that can release drugs in response to specific biological triggers. Advances in nanobiotechnology and personalized medicine will enable the design of tailored therapies that match individual patient profiles, enhancing treatment outcomes.
